NCT02807220View on ClinicalTrials.gov

Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

April 13, 2017

Study Completion Date

April 13, 2017

Conditions
Cold Symptoms
Interventions
DRUG

Imuneks 10mg

Two capsules of the study drug every morning approximately two hours after breakfast for six weeks

Trial Locations (1)

38039

Erciyes University Hakan Çetinsaya İKU, Kayseri

All Listed Sponsors
collaborator

TC Erciyes University

OTHER

lead

Imuneks Farma ilac San. Tic. A.S.

INDUSTRY

NCT02807220 - Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold | Biotech Hunter | Biotech Hunter